Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies
Science China Life Sciences · 2025
DOI: 10.1007/s11427-024-2835-y ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Science China Life Sciences, 2025. Verfasst von Jianlin Zhou und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People's Hospital, …. Hauptthemen laut MEDLINE: Adaptive Immunity, Mycoses, Fungi, Receptors, Pattern Recognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 273 Literaturangaben.
Abstract (Originalsprache)
As a common disease in human life, fungal infection poses a serious threat to human life and health. Moreover, owing to the rapid development of the immune escape mechanisms of fungi and the emergence of new drug-resistant fungi, existing therapeutic drugs are no longer able to meet the treatment needs of patients. In particular, the World Health Organization (WHO) published the first Fungal Priority Pathogens List (FPPL) in 2022, further emphasizing that we need to pay more attention to invasive fungal infections. In addition, the WHO has called for increased global investment in fungal infections and the development of antifungal drugs. In this review, we introduce the mechanism by which innate immune cell PRRs recognize fungal pathogen PAMPs, the role of adaptive immune cells in antifungal immunity, fungal infections caused by immune deficiencies, and the latest research progress in immune-based fungal therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Key Laboratory for Human Disease Gene Study of Sichuan Province and the Department of Laboratory Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of…
- Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 611731, China.
- Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 611731, China. lingyunfeng@uestc.edu.cn.
- Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 611731, China. yimingemail1234@163.com.
- Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 611731, China. wangyuan_med@uestc.edu.cn.
- Research Unit for Blindness Prevention of the Chinese Academy of Medical Sciences, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, 611731, China. wangch@uestc.edu.cn.
Zitieren
APA
Zhou, J., Lu, X., He, R., Du, Y., Zeng, B., Feng, L., Yi, M., Wang, Y., & Wang, C. (2025). Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies. Science China Life Sciences. https://doi.org/10.1007/s11427-024-2835-y
Vancouver
Zhou J, Lu X, He R, Du Y, Zeng B, Feng L, et al. Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies. Science China Life Sciences. 2025. doi:10.1007/s11427-024-2835-y
BibTeX
@article{Zhou2025,
author = {Zhou, Jianlin and Lu, Xueni and He, Ruirui and Du, Yanyun and Zeng, Bo and Feng, Lingyun and Yi, Ming and Wang, Yuan and Wang, Chenhui},
title = {Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies},
journal = {Science China Life Sciences},
year = {2025},
doi = {10.1007/s11427-024-2835-y}
}
EUVIMED